Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19

Chiara Agrati, Stefania Capone, Concetta Castilletti, Eleonora Cimini, Giulia Matusali, Silvia Meschi, Eleonora Tartaglia, Roberto Camerini, Simone Lanini, Stefano Milleri, Stefano Colloca, Alessandra Vitelli, Antonella Folgori
doi: https://doi.org/10.1101/2021.06.22.21258961

Article Information

doi 
https://doi.org/10.1101/2021.06.22.21258961
History 
  • June 28, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Chiara Agrati1,†,*,
  2. Stefania Capone2,†,
  3. Concetta Castilletti1,
  4. Eleonora Cimini1,
  5. Giulia Matusali1,
  6. Silvia Meschi1,
  7. Eleonora Tartaglia1,
  8. Roberto Camerini2,
  9. Simone Lanini1,
  10. Stefano Milleri3,
  11. Stefano Colloca2,
  12. Alessandra Vitelli2 and
  13. Antonella Folgori2
  1. 1Istituto Nazionale per Le Malattie Infettive Lazzaro Spallanzani IRCCS; Rome, Italy
  2. 2ReiThera Srl; Rome, Italy
  3. 3Centro Ricerche Cliniche di Verona srl; Verona, Italy
  1. ↵*Corresponding author. Email: chiara.agrati{at}inmi.it

  1. ↵† These authors contributed equally to this work

Back to top
Posted June 28, 2021.
Download PDF
Data/Code
Email
Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19
Chiara Agrati, Stefania Capone, Concetta Castilletti, Eleonora Cimini, Giulia Matusali, Silvia Meschi, Eleonora Tartaglia, Roberto Camerini, Simone Lanini, Stefano Milleri, Stefano Colloca, Alessandra Vitelli, Antonella Folgori
medRxiv 2021.06.22.21258961; doi: https://doi.org/10.1101/2021.06.22.21258961
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area